Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,522 | 23,342 | 5,598 | 1,701 | 5,750 |
| TOTAL | $13,424 | $24,475 | $7,206 | $2,354 | $6,130 |
| Non-Current Assets | |||||
| PPE Net | 652 | 717 | 783 | 848 | 23 |
| Other Non-Current Assets | 950 | 977 | 1,003 | 750 | 93 |
| TOTAL | $1,602 | $1,694 | $1,786 | $1,598 | $116 |
| Total Assets | $15,026 | $26,169 | $8,992 | $3,952 | $6,246 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,034 | 7,998 | 13,309 | 8,999 | 410 |
| Accrued Expenses | 17,008 | 12,842 | 13,725 | 14,478 | 986 |
| Other current liabilities | N/A | N/A | N/A | 79,870 | N/A |
| TOTAL | $25,042 | $20,840 | $27,034 | $103,347 | $1,396 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 49 | 71 | 250 | 280 | 0 |
| TOTAL | $49 | $71 | $250 | $280 | $N/A |
| Total Liabilities | $25,091 | $20,911 | $27,284 | $103,627 | $1,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | 14 | 9 | 9 | 1 |
| Common Shares | 3 | 3 | 2 | N/A | 1 |
| Retained earnings | -418,165 | -399,734 | -376,490 | -307,277 | -133,484 |
| Other shareholders' equity | 0 | 0 | 0 | 189,871 | 0 |
| TOTAL | $-10,065 | $5,258 | $-18,292 | $-99,675 | $4,850 |
| Total Liabilities And Equity | $15,026 | $26,169 | $8,992 | $3,952 | $6,246 |